| Literature DB >> 31575004 |
David B Needle1, Robert Gibson2, Nicholas A Hollingshead3, Inga F Sidor4, Nicholas J Marra5, Derek Rothenheber6, Anil J Thachil7, Bryce J Stanhope8, Brian A Stevens9, Julie C Ellis10, Shelley Spanswick11, Maureen Murray12, Laura B Goodman13.
Abstract
Twelve wild North American porcupines (Erethizon dorsatum) out of a total of 44 of this species examined in an 8-year period were diagnosed with dermatopathies while being cared for at two wildlife rehabilitation clinics. Biopsy and necropsy were performed on seven and five animals, respectively. Atypical dermatophytosis was diagnosed in all cases. Lesions consisted of diffuse severe epidermal hyperkeratosis and mild hyperplasia with mild lymphoplasmacytic dermatitis and no folliculitis. Dermatophytes were noted histologically as hyphae and spores in hair shafts, and follicular and epidermal keratin. Trichophyton sp. was grown in 5/6 animals where culture was performed, with a molecular diagnosis of Arthroderma benhamiae/Trichophyton mentagrophytes in these five cases. Metagenomic analysis of formalin-fixed paraffin-embedded tissue samples from three cases identified fungi from 17 orders in phyla Basidiomycota and Ascomycota. Alteration of therapy from ketaconazole, which was unsuccessful in four out of five early cases, to terbinafine or nitraconazole led to the resolution of disease and recovery to release in four subsequent animals. In all, six animals were euthanized or died due to dermatopathy, no cases resolved spontaneously, and six cases were resolved with therapy. The work we present demonstrates an atypical lesion and anatomical distribution due to dermatophytosis in a series of free-ranging wild porcupines and the successful development of novel techniques for extracting and sequencing nucleic acids from fungus in archival formalin-fixed paraffin-embedded animal tissue.Entities:
Keywords: Erethizon; dermatophyte; fungal genetics; fungus; metagenomics; molecular diagnostics; porcupine
Year: 2019 PMID: 31575004 PMCID: PMC6963859 DOI: 10.3390/pathogens8040171
Source DB: PubMed Journal: Pathogens ISSN: 2076-0817
Case descriptions.
| Animal # | Year | Location Found/Origin | Signalment | Treatments | Outcome (Died/Euth/Released) |
|---|---|---|---|---|---|
| 1 | 2010 | Kittery Point, ME | Juv M | Ketaconazole 20 mg/kg SID 19 days; Baytril 5 mg/kg BID 3 day; Gentak ointment BID-TID 21 days; Vetropolycin BID 3 days; Optimmune ointment SID 1 day; | Died |
| 2 | 2010 | Kennebunk, ME | Juv M | Ketaconazole 20 mg/kg & 30 mg/kg SID (dosage was increased); Sulfatrim 30 mg/kg BID 10 days; Gentacin ointment SID 7 days | Euthanized |
| 3 | 2011 | Eliot, ME | Ad M | Ketaconazole 20 mg/kg at least 4 weeks | Died |
| 4 | 2012 | Deerfield, NH | <1y F |
| Euthanized |
| 5 | 2013 | Huntington, MA | Ad F | Ketaconazole 15 mg/kg SID | Released |
| 6 | 2015 | Rockingham County, NH | Juv M | Ketaconazole 30 mg/kg SID; Ivermectin 0.2 mg/kg SQ | Euthanized |
| 7 | 2016 | Barrington, NH | M |
| Released |
| 8 | 2017 | North Berwick, ME | Ad M |
| Euthanized |
| 9 | 2017 | Wells, ME | Ad M |
| Released |
| 10 | 2017 | Sandbornville, NH | Ad F | ivermectin SQ; terbinafine 125 mg/mL; 30 mg/kg | Released |
| 11 | 2017 | Turner, ME | Ad M |
| Released |
| 12 | 2017 | York, ME | Ad M | nitraconazole 200 mg BID 14 d; Terbinafine 100 mg SID 32 d | Released |
Abbreviations: Ad—adult; Juv—juvenile; F—female; M—male; SID—once a day; BID—twice a day; SQ—subcutaneous.
Summary of diagnostic testing performed.
| Animal # | Tests Performed | Culture Findings | Molecular Diagnostics (Specimen Tested—Result) | Additional Necropsy Findings |
|---|---|---|---|---|
| 1 | Necropsy; FFPE metagenomics | Culture not performed | FFPE—primarily | (1) Fibrinonecrotizing neutrophilic pneumonia; (2) Chronic cerebrocortical necrosis (suspected infarct); (3) Hepatic and esophageal subacute fibrinoid phlebitis; (4) Marked intestinal cestodiasis; (5) Marked colonic nematodiasis |
| 2 | Necropsy; FFPE metagenomics | Culture not performed | FFPE—poor DNA yield/ no amplification | (1) Subacute lymphohistiocytic interstitial myocarditis; (2) Eosinophilic and neutrophilic bronchopneumonia; (3) Marked intestinal cestodiasis |
| 3 | Necropsy; Fungal culture; D1-D2 large subunit RNA PCR and sequencing | culture— | (1) Incisor overgrowth & marked molar wear; (2) Skeletal myofiber atrophy; (3) Rib fractures; (4) Marked intestinal cestodiasis; (5) Moderate colonic nematodiasis; (6) Subacute lymphohistiocytic myocarditis; (7) Thalamic gliosis and sclerosis with minimal encephalitis | |
| 4 | Biopsy; FFPE metagenomics | Culture not performed | FFPE—poor DNA yield/ no amplification | n/a—biopsy only |
| 5 | Biopsy; FFPE metagenomics | Culture not performed | FFPE—primarily | n/a—biopsy only |
| 6 | Necropsy; dermatophyte test media culture (DTM); FFPE metagenomics | DTM + | FFPE—primarily | (1) Granulomatous peritonitis with abdominal perforation, intestinal entrapment and rupture (presumptive trauma); (2) Moderate intestinal cestodiasis; (3) Moderate colonic nematodiasis; (4) Chronic cerebrocortical astrogliosis and microgliosis; (5) Subacute hepatocellular necrosis (presumptive larval migration) |
| 7 | Biopsy; FFPE metagenomics | Culture not performed | FFPE—primarily | n/a—biopsy only |
| 8 | Necropsy; culture; D1-D2 large subunit RNA PCR and sequencing | culture— | (1) Chronic granulomatous and eosinophilic capsular splenitis; (2) Marked intestinal cestodiasis; (3) Marked colonic nematodiasis | |
| 9 | Biopsy; culture; D1-D2 large subunit RNA; metagenomics on culture | culture— | n/a—biopsy & culture only | |
| 10 | Biopsy; culture; D1-D2 large subunit RNA; metagenomics on culture | Mixed | culture—mixedprimarily | n/a—biopsy & culture only |
| 11 | Biopsy; culture; D1-D2 large subunit RNA; metagenomics on culture | culture— | n/a—biopsy & culture only | |
| 12 | Biopsy; culture; D1-D2 large subunit RNA; metagenomics on culture | culture— | n/a—biopsy & culture only |
Abbreviations: FFPE—formalin-fixed, paraffin-embedded tissue; n/a—not applicable.
Figure 1Geographic distribution of cases of dermatophytosis in the 12 wild NAPs in New England. Numbers correspond to case numbers assigned in Table 1.
Figure 2Dermatophytosis in a NAP, animal 8. Gross lesions characterized by severe hyperkeratosis that was readily visible covering the skin on its natural surface and appeared as thick white flaking crusts (top); in the cut section the hyperkeratosis was arranged in a thick, diffuse mat of overlapping sheets, measuring up to 5 mm thick (bottom).
Figure 3Dermatophytosis in a NAP, animal 8; hematoxylin and eosin. Marked hyperkeratosis extended from the epidermal surface outward, with moderate underlying epidermal hyperplasia. The inset shows minimal/negligible inflammation in the dermis.
Figure 4Dermatophytosis in a NAP, animal 8, HE left (larger) image and periodic acid-Schiff highlighting the fungal organisms in both of the inset images on the right. The dermatophyte herein was characterized by round to oval, 2–6 µm diameter fungal arthrospores colonizing the cortices of hair shafts notable in HE staining (large figure, left side). The two smaller figures show bright pink periodic acid-Schiff (PAS) staining of the arthrospores (top right) as well as slender, 4–7 µm diameter, undulating, frequently septate, and rarely branching hyphae in the follicular keratin (bottom right).
Figure 5Dermatophytosis in a NAP, five cultures in dermatophyte test medium. From left to right are cases 8–12, respectively. The medium contained a phenol red pH indicator for species producing alkaline metabolites (Epidermophyton, Microsporum, and Trichophyton spp.). Cultures from cases 8, 9, 11, and 12 were characterized by white fungal colonies with powdery surfaces. Case 10 (central) was mixed and characterized by heavy grey-green mold.
Figure 6Fungal composition based on phyla (A) and class (B). Taxonomic assignments from 28S metagenomic sequencing of mixed or pure cultures were compared with direct sequencing from formalin fixed paraffin-embedded tissues (FFPE).